Suchergebnisse - "SIMPSON IAIN"

PubPharm (256)

91

Corrigendum to "2019 ESC/EAS Guidelines for the management of dyslipidaemias : lipid modification to reduce cardiovascular risk" [Atherosclerosis 290 (2019) 140-205

enthalten in: Atherosclerosis | 2020

von Task Force Members | ESC National Cardiac Societies | ESC Committee for Practice Guidelines (CPG) | +100

ErratumFor: Atherosclerosis. 2019 Nov;290:140-205. - PMID 31591002

92

2019 ESC Guidelines for the management of patients with supraventricular tachycardiaThe Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC)

enthalten in: European heart journal | 2020

von Brugada, J. | Katritsis, D. | Arbelo, E. | +119

ErratumIn: Eur Heart J. 2020 Nov 21;41(44):4258. - PMID 31837137

93

2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)

enthalten in: European heart journal | 2020

von Konstantinides, S. | Meyer, G. | Becattini, C. | +121

CommentIn: Vasa. 2020 Jun;49(4):257-258. - PMID 32578520

94

Erratum to "2019 ESC/EAS guidelines for the management of dyslipidemias : Lipid modification to reduce cardiovascular risk" [Atherosclerosis 290 (2019) 140-205

enthalten in: Atherosclerosis | 2020

von Authors/Task Force Members | ESC National Cardiac Societies | ESC Committee for Practice Guidelines (CPG) | +100

ErratumFor: Atherosclerosis. 2019 Nov;290:140-205. - PMID 31591002

95

2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes

enthalten in: European heart journal | 2020

von Knuuti, J. | Wijns, W. | Saraste, A. | +123

CommentIn: Herz. 2019 Dec;44(8):674-675. - PMID 31797012

96

2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

enthalten in: European heart journal | 2020

von Cosentino, F. | Grant, P. | Aboyans, V. | +122

CommentIn: Anatol J Cardiol. 2019 Nov;22(5):214-218. - PMID 31674936

97

IMIDAZO[4,5-C]PYRIDINE AND PYRROLO[2,3-C]PYRIDINE DERIVATIVES AS SSAO INHIBITORS

enthalten in: Europäisches Patentamt | 2020

von ESPENSEN MAX | PATIENT LEE | EVANS DAVID | +2

98

Therapeutic delivery: industry update covering November 2019

enthalten in: Therapeutic Delivery | 2020

von Simpson, I.

99

2019 ESC/EAS Guidelines for the management of dyslipidaemias : lipid modification to reduce cardiovascular risk

enthalten in: European heart journal | 2020

von Mach, F. | Baigent, C. | Catapano, A. | +119

ErratumIn: Eur Heart J. 2020 Nov 21;41(44):4255. - PMID 31837134

100

Discovery of a Potent and Selective Oral Inhibitor of ERK1/2 (AZD0364) That Is Efficacious in Both Monotherapy and Combination Therapy in Models of Nonsmall Cell Lung Cancer (NSCLC)

enthalten in: Journal of medicinal chemistry | 2019

von Ward, R. | Anderton, M. | Bethel, P. | +35